Trial intelligence / Profile preview

Gabapentin for postmenopausal sleep disturbance and quality of life

IRCT201304184686N3Phase 2Completed

Sponsor
Arak University of Medical Sciences
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of gabapentin in sleep disorder, sponsored by Arak University of Medical Sciences. Started May 2013; status: completed.

02

Drugs

gabapentin
03

Conditions

sleep disorder

Beyond the preview

Go deeper on IRCT201304184686N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201304184686N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call